Literature DB >> 1471893

Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis.

R Caporali1, A Ravelli, B Ramenghi, C Montecucco, A Martini.   

Abstract

A child with systemic onset juvenile chronic arthritis (JCA) who developed a bilateral femuropopliteal vein thrombosis after plaster immobilisation following a tibial fracture is described. When the thrombosis was diagnosed, antiphospholipid antibodies detected either as lupus anticoagulant and anticardiolipin antibodies were found. This suggests that short term prophylatic antithrombotic treatment should be considered in antiphospholipid antibody positive JCA patients who require immobilisation after fractures of demineralised bones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471893      PMCID: PMC1793776          DOI: 10.1136/adc.67.11.1384

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al.

Authors:  R A Asherson; E N Harris; G R Hughes; R G Farquharson
Journal:  Arthritis Rheum       Date:  1988-04

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

3.  Anticardiolipin syndrome in childhood: a report of two cases.

Authors:  A Ravelli; R Caporali; E Bianchi; S Viola; M Solmi; C Montecucco; A Martini
Journal:  Clin Exp Rheumatol       Date:  1990 Jan-Feb       Impact factor: 4.473

4.  Prevalence of anticardiolipin antibodies in juvenile chronic arthritis.

Authors:  R Caporali; A Ravelli; F De Gennaro; G Neirotti; C Montecucco; A Martini
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

5.  Thrombosis in systemic lupus erythematosus: a French collaborative study.

Authors:  M A Montes de Oca; M C Babron; O Blétry; M Broyer; V Courtecuisse; J L Fontaine; C Loirat; J P Méry; P Reinert; B Wechsler
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

  5 in total
  4 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

Review 3.  Antiphospholipid antibodies in paediatrics.

Authors:  A Ravelli; A Martini; G R Burgio
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

Review 4.  Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.

Authors:  Silvia Rosina; Cecilia Beatrice Chighizola; Angelo Ravelli; Rolando Cimaz
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.